Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...

FDA requests Tavneos market withdrawal due to ADVOCATE trial assessment concerns; Amgen maintains the drug's benefit-risk profile remains positive.

Heart failure management includes the four pillars (quad therapy) in HFrEF and HFpEF, plus advances in heart transplantation and gene editing.

In patients starting gout medication, hitting a target serum urate level below 6 mg/dL reduces the risk of major ...

Men have a significantly higher risk for premature cardiovascular disease (CVD) and a significantly earlier onset compared with women.

Most US adults have heard of statins to lower cholesterol, but many do not know there are nonstatin medications.

White matter hyperintensity (WMH) burden predicts functional decline in real-world driving among older adults.

Women with a previous history of ischemic stroke have doubled odds of having another ischemic stroke during pregnancy or early postpartum.

For patients after ischemic stroke, extremely low-frequency, low-intensity electromagnetic field brain stimulation reduces disability.

Although the cause of death of prominent actress Catherine O’Hara — Schitt’s Creek, Beetlejuice, and Home Alone — is still ...

Andexxa is a recombinant modified human factor Xa protein that received accelerated approval in 2018 for reversal of anticoagulation with rivaroxaban or apixaban due to life-threatening or ...

About one in five patients with CeAD have dissecting aneurysm (DA), but they do not have an increased risk for subsequent ischemic stroke.